Accueil
Détail de l'auteur
Documents disponibles écrits par cet auteur
Ajouter le résultat dans votre panier Faire une suggestion Affiner la rechercheArticle : Périodique
S. MEZAACHE ; C. PROTOPOPESCU ; M. DEBRUS ; S. MOREL ; M. MORA ; M. SUZAN-MONTI ; D. ROJAS CASTRO ; P. CARRIERI ; P. ROUX |Background: People who inject drugs face several health issues because of unsafe injecting practices. We aimed to evaluate changes in supervised drug-injecting practices following the implementation of a face-to-face educational intervention. M[...]Article : Périodique
L. BRIAND MADRID ; S. MOREL ; K. NDIAYE ; S. MEZAACHE ; D. ROJAS CASTRO ; M. MORA ; F. OLIVET ; V. LAPORTE ; C. PROTOPOPESCU ; P. CARRIERI ; P. ROUX |Background: Regular consumption of opioids exposes individuals to several side effects. One of these is a loss of libido, which has a negative impact on quality of life. We used a cross-sectional community-based survey of people who inject opioi[...]Périodique
P. VERGER ; M. AULAGNIER ; C. PROTOPOPESCU ; VILLANI P. ; GOURRHEUX J.-C. ; BOUVENOT G. ; A. PARAPONARIS | 2004ENGLISH : Previous research suggests that practising physicians are more likely than the general population to use psychotropic drugs. Hypnotic and tranquillizer use in France is among the highest in Europe; most hypnotic and tranquillizer pre[...]Article : Périodique
P. ROUX ; D. ROJAS CASTRO ; K. NDIAYE ; M. DEBRUS ; C. PROTOPOPESCU ; J. M. LE GALL ; A. HAAS ; M. MORA ; B. SPIRE ; M. SUZAN-MONTI ; P. CARRIERI |Aims: The community-based AERLI intervention provided training and education to people who inject drugs (PWID) about HIV and HCV transmission risk reduction, with a focus on drug injecting practices, other injection-related complications, and ac[...]Article : Périodique
P. ROUX ; J. M. LE GALL ; M. DEBRUS ; C. PROTOPOPESCU ; K. NDIAYE ; B. DEMOULIN ; C. LIONS ; A. HAAS ; M. MORA ; B. SPIRE ; M. SUZAN-MONTI ; M. P. CARRIERI |ENGLISH: Aims: To study the effectiveness of an educational intervention on risks associated with drug injection, comparing primary [unsafe HIV-hepatitis C virus (HCV) practices] and secondary (local complications at injecting site) end-points [...]Article : Périodique
T. ROJAS ROJAS ; V. DI BEO ; J. DELORME ; T. BARRE ; P. MATHURIN ; C. PROTOPOPESCU ; F. BAILLY ; M. COSTE ; N. AUTHIER ; M. P. CARRIERI ; B. ROLLAND ; F. MARCELLIN |Background: In the era of direct-acting antivirals (DAA) for the treatment of hepatitis C virus (HCV) infection, HCV treatment uptake remains insufficiently documented in key populations such as people with opioid dependence. Access to opioid ag[...]Nouveauté
Article : Périodique
M. PREAU ; A. D. BOUHNIK ; I. POIZOT-MARTIN ; C. PROTOPOPESCU ; M. P. CARRIERI ; H. GALLAIS ; J. P. MOATTI ; B. SPIRE ; The MANIF 2000 Study Group ; Groupe d'étude MANIF 2000 |La présence de symptômes dépressifs apparaît comme l'un des enjeux majeurs de la prise en charge de l'infection par le VIH du fait de son rôle fondamental quant au succès thérapeutique des multithérapies antirétrovirales, et cela plus particuliè[...]Article : Périodique
P. ROUX ; S. MEZAACHE ; L. BRIAND-MADRID ; M. DEBRUS ; N. KHATMI ; G. MARADAN ; C. PROTOPOPESCU ; D. ROJAS-CASTRO ; P. CARRIERI |Aims: In France, a non-negligible proportion of opioid-dependent individuals inject morphine sulfate. Although it has not yet been officially approved as an opioid substitution treatment (OST), some physicians can prescribe its use for people in[...]
